Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore to Use €545K in Funding to Hire Software-Development, Sales Staff

NEW YORK (GenomeWeb) – Qlucore has received €545,000 (about $579,000) in funding from a rights issue and a development loan from Swedish regional development fund ALMI, which it will use to hire software development staff for its head office in Lund, Sweden and also to increase its sales force in the US.

"We are grateful to ALMI and the shareholders of Qlucore for supporting the growth ambitions of the firm's management," Carl-Johan Ivarsson, Qlucore's president, said in a statement. He added that the investment will "significantly enhance" the speed of Qlucore's continued growth particularly in the US market, which the company sees as key to its future success.

Qlucore began its days as a collaborative research project at Lund University in 2007. The company markets Qlucore Omics Explorer, software for visualizing, exploring, analyzing, and sharing omics datasets. The tool offers interactive 3D visualizations, statistical support, and streamlined workflows for analyzing multiple data types.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.